Go to
JCI Insight
Citations to this article
Sara Falck-Jones, … , Anna Färnert, Anna Smed-Sörensen
Published January 25, 2021
Citation Information: J Clin Invest. 2021;131(6):e144734. https://doi.org/10.1172/JCI144734.
Citation Information: J Clin Invest. 2021;131(6):e144734. https://doi.org/10.1172/JCI144734.
Abstract
The immunopathology of coronavirus disease 2019 (COVID-19) remains enigmatic, causing immunodysregulation and T cell lymphopenia. Monocytic myeloid-derived suppressor cells (M-MDSCs) are T cell suppressors that expand in inflammatory conditions, but their role in acute respiratory infections remains unclear. We studied the blood and airways of patients with COVID-19 across disease severities at multiple time points. M-MDSC frequencies were elevated in blood but not in nasopharyngeal or endotracheal aspirates of patients with COVID-19 compared with healthy controls. M-MDSCs isolated from patients with COVID-19 suppressed T cell proliferation and IFN-γ production partly via an arginase 1–dependent (Arg-1–dependent) mechanism. Furthermore, patients showed increased Arg-1 and IL-6 plasma levels. Patients with COVID-19 had fewer T cells and downregulated expression of the CD3ζ chain. Ordinal regression showed that early M-MDSC frequency predicted subsequent disease severity. In conclusion, M-MDSCs expanded in the blood of patients with COVID-19, suppressed T cells, and were strongly associated with disease severity, indicating a role for M-MDSCs in the dysregulated COVID-19 immune response.
Authors
Sara Falck-Jones, Sindhu Vangeti, Meng Yu, Ryan Falck-Jones, Alberto Cagigi, Isabella Badolati, Björn Österberg, Maximilian Julius Lautenbach, Eric Åhlberg, Ang Lin, Rico Lepzien, Inga Szurgot, Klara Lenart, Fredrika Hellgren, Holden Maecker, Jörgen Sälde, Jan Albert, Niclas Johansson, Max Bell, Karin Loré, Anna Färnert, Anna Smed-Sörensen
Citation information
Citations to this article (79)
| Title and authors | Publication | Year |
|---|---|---|
|
Herbal and Dietary Supplements as Adjunctive Treatment for Mild SARS-CoV-2 Infection in Italy
Licata A, Seidita A, Como S, de Carlo G, Cammilleri M, Bonica R, Soresi M, Veronese N, Chianetta R, Citarrella R, Giannitrapani L, Barbagallo M |
Nutrients | 2025 |
|
Global Trends in Research of Amino Acid Metabolism in T Lymphocytes in Recent 15 Years: A Bibliometric Analysis
Xu J, Yu Y, Li S, Qiu F |
Journal of Immunology Research | 2025 |
|
Decreased levels and function of dendritic cells in blood and airways predict COVID‐19 severity
Österberg B, Falck\u2010Jones S, Vangeti S, Åhlberg E, Yu M, Granja D, Snik ME, Falck\u2010Jones R, Barros GW, Charles A, Lepzien R, Johansson N, Holmes TH, Maecker H, Czarnewski P, Bell M, Färnert A, Smed\u2010Sörensen A |
Clinical & Translational Immunology | 2025 |
|
The CD38+HLA-DR+ T cells with activation and exhaustion characteristics as predictors of severity and mortality in COVID-19 patients
Long Q, Song S, Xue J, Yu W, Zheng Y, Li J, Wu J, Hu X, Jiang M, Ye H, Zheng B, Wang M, Wu F, Li K, Gao Z, Zheng Y |
Frontiers in Immunology | 2025 |
|
Unveiling the role of the upper respiratory tract microbiome in susceptibility and severity to COVID-19
von Ameln Lovison O, Zempulski Volpato FC, Weber LG, Barth AL, Simon Coitinho A, Martins AF |
Frontiers in Cellular and Infection Microbiology | 2025 |
|
Modulation of innate immune activity after infection or repetitive mRNA vaccination in humans
Fredrika Hellgren, Anja Rosdahl, Rodrigo Arcoverde Cerveira, Klara Lenart, Sebastian Ols, Yongdae Kwon, Seta Kurt, Anna-Maria Delis, Magnus Evander, Johan Normark, Clas Ahlm, Mattias N Forsell, Sara Cajander, Karin Lore |
JCI Insight | 2024 |
|
COVID-19 PBMCs are doubly harmful, through LDN-mediated lung epithelial damage and monocytic impaired responsiveness to live Pseudomonas aeruginosa exposure
Gaudin C, Born-Bony M, Villeret B, Jaillet M, Faille D, Timsit JF, Tran-Dinh A, Montravers P, Crestani B, Garcia-Verdugo I, Sallenave JM |
Frontiers in immunology | 2024 |
|
Impact of Hyponatremia on COVID-19-Related Outcomes: A Retrospective Analysis
Piza PM, de Freitas VM, Aguiar-Brito I, Calsolari-Oliveira BM, Rangel ÉB |
Biomedicines | 2024 |
|
Spleen tyrosine kinase inhibition restores myeloid homeostasis in COVID-19
Wigerblad G, Warner SA, Ramos-Benitez MJ, Kardava L, Tian X, Miao R, Reger R, Chakraborty M, Wong S, Kanthi Y, Suffredini AF, Dell\u2019Orso S, Brooks S, King C, Shlobin O, Nathan SD, Cohen J, Moir S, Childs RW, Kaplan MJ, Chertow DS, Strich JR |
Science Advances | 2023 |
|
Major alterations to monocyte and dendritic cell subsets lasting more than 6 months after hospitalization for COVID-19
Hopkins FR, Govender M, Svanberg C, Nordgren J, Waller H, Nilsdotter-Augustinsson Å, Henningsson AJ, Hagbom M, Sjöwall J, Nyström S, Larsson M |
Frontiers in immunology | 2023 |
|
Early peripheral blood MCEMP1 and HLA-DRA expression predicts COVID-19 prognosis
Chan KR, Koh CW, Ng DH, Qin S, Ooi JS, Ong EZ, Zhang SL, Sam H, Kalimuddin S, Low JG, Ooi EE |
EBioMedicine | 2023 |
|
Human influenza virus infection elicits distinct patterns of monocyte and dendritic cell mobilization in blood and the nasopharynx
Vangeti S, Falck-Jones S, Yu M, Österberg B, Liu S, Asghar M, Sondén K, Paterson C, Whitley P, Albert J, Johansson N, Färnert A, Smed-Sörensen A |
eLife | 2023 |
|
Advances in the study of myeloid-derived suppressor cells in infectious lung diseases
Zhang MN, Yuan YL, Ao SH |
Frontiers in immunology | 2023 |
|
Delayed generation of functional virus-specific circulating T follicular helper cells correlates with severe COVID-19.
Yu M, Charles A, Cagigi A, Christ W, Österberg B, Falck-Jones S, Azizmohammadi L, Åhlberg E, Falck-Jones R, Svensson J, Nie M, Warnqvist A, Hellgren F, Lenart K, Arcoverde Cerveira R, Ols S, Lindgren G, Lin A, Maecker H, Bell M, Johansson N, Albert J, Sundling C, Czarnewski P, Klingström J, Färnert A, Loré K, Smed-Sörensen A |
Nature Communications | 2023 |
|
Here, There and Everywhere: Myeloid-derived Suppressor Cells in Immunology
Ostrand-Rosenberg S, Lamb TJ, Pawelec G |
Journal of immunology (Baltimore, Md. : 1950) | 2023 |
|
Maintained imbalance of triglycerides, apolipoproteins, energy metabolites and cytokines in long-term COVID-19 syndrome patients
Berezhnoy G, Bissinger R, Liu A, Cannet C, Schäfer H, Kienzle K, Bitzer M, Häberle H, Göpel S, Trautwein C, Singh Y |
Frontiers in immunology | 2023 |
|
Inflammatory and tolerogenic myeloid cells determine outcome following human allergen challenge.
Voskamp AL, Tak T, Gerdes ML, Menafra R, Duijster E, Kielbasa SM, Kormelink TG, Stam KA, van Hengel ORJ, de Jong NW, Hendriks RW, Kloet SL, Yazdanbakhsh M, de Jong EC, Gerth van Wijk R, Smits HH |
Journal of Experimental Medicine | 2023 |
|
Suppressive myeloid cells in SARS-CoV-2 and Mycobacterium tuberculosis co-infection
Shaw JA, Malherbe ST, Walzl G, du Plessis N |
Frontiers in immunology | 2023 |
|
A myeloid program associated with COVID-19 severity is decreased by therapeutic blockade of IL-6 signaling
Hackney JA, Shivram H, Vander Heiden J, Overall C, Orozco L, Gao X, Kim E, West N, Qamra A, Chang D, Chakrabarti A, Choy DF, Combes AJ, Courau T, Fragiadakis GK, Rao AA, Ray A, Tsui J, Hu K, Kuhn NF, Krummel MF, Erle DJ, Kangelaris K, Sarma A, Lyon Z, Calfee CS, Woodruff PG, Ghale R, Mick E, Byrne A, Zha BS, Langelier C, Hendrickson CM, van der Wijst MG, Hartoularos GC, Grant T, Bueno R, Lee DS, Greenland JR, Sun Y, Perez R, Ogorodnikov A, Ward A, Ye CJ, Ramalingam T, McBride JM, Cai F, Teterina A, Bao M, Tsai L, Rosas IO, Regev A, Kapadia SB, Bauer RN, Rosenberger CM |
iScience | 2023 |
|
Presence of MDSC associates with impaired antigen-specific T cell reactivity following COVID-19 vaccination in cirrhotic patients
Törnell A, Blick E, Al-Dury S, Grauers Wiktorin H, Waern J, Ringlander J, Einarsdottir S, Lindh M, Hellstrand K, Lagging M, Martner A |
Frontiers in immunology | 2023 |
|
Circulating myeloid-derived suppressor cells may be a useful biomarker in the follow-up of unvaccinated COVID-19 patients after hospitalization
Jiménez-Cortegana C, Salamanca E, Palazón-Carrión N, Sánchez-Jiménez F, Pérez-Pérez A, Vilariño-García T, Fuentes S, Martín S, Jiménez M, Galván R, Rodríguez-Chacón C, Sánchez-Mora C, Moreno-Mellado E, Gutiérrez-Gutiérrez B, Álvarez N, Sosa A, Garnacho-Montero J, de la Cruz-Merino L, Rodríguez-Baño J, Sánchez-Margalet V |
Frontiers in immunology | 2023 |
|
Immunomodulatory actions of myeloid-derived suppressor cells in the context of innate immunity
Bizymi N, Matthaiou AM, Mavroudi I, Batsali A, Papadaki HA |
Innate immunity | 2023 |
|
Enrichment of a neutrophil-like monocyte transcriptional state in glioblastoma myeloid suppressor cells
Wiencke JK, Nissen E, Koestler DC, Tamaki SJ, Tamaki CM, Hansen HM, Warrier G, Hadad S, McCoy L, Rice T, Clarke J, Taylor JW, Salas LA, Christensen BC, Kelsey KT, Butler R, Molinaro AM |
Research square | 2023 |
|
The Functional Roles of MDSCs in Severe COVID-19 Pathogenesis.
Len JS, Koh CWT, Chan KR |
Viruses | 2023 |
|
Functional reprogramming of monocytes in acute and convalescent severe COVID-19 patients
Elisa Brauns, Abdulkader Azouz, David Grimaldi, Hanxi Xiao, Séverine Thomas, Muriel Nguyen, Véronique Olislagers, Ines Vu Duc, Carmen Orte Cano, Véronique Del Marmol, Pieter Pannus, Frédérick Libert, Sven Saussez, Nicolas Dauby, Jishnu Das, Arnaud Marchant, Stanislas Goriely |
JCI Insight | 2022 |
|
Mucosal immune responses to infection and vaccination in the respiratory tract
R Mettelman, E Allen, P Thomas |
Immunity | 2022 |
|
New Discovery of Myeloid-Derived Suppressor Cell’s Tale on Viral Infection and COVID-19
S Park, D Nam, H Seong, Y Hahn |
Frontiers in immunology | 2022 |
|
Hematopoietic responses to SARS-CoV-2 infection
S Elahi |
Cellular and Molecular Life Sciences | 2022 |
|
Circulating biomarkers of inflammaging as potential predictors of COVID-19 severe outcomes
J Sabbatinelli, G Matacchione, A Giuliani, D Ramini, M Rippo, A Procopio, M Bonafè, F Olivieri |
Mechanisms of Ageing and Development | 2022 |
|
Mechanistic Insights Into the Immune Pathophysiology of COVID-19; An In-Depth Review
A Shafqat, S Shafqat, S Salameh, J Kashir, K Alkattan, A Yaqinuddin |
Frontiers in immunology | 2022 |
|
Stem cell therapy for COVID-19 pneumonia
M Kebria, P Milan, N Peyravian, J Kiani, S Khatibi, M Mozafari |
2022 | |
|
Healthy myeloid-derived suppressor cells express the surface ectoenzyme Vanin-2 (VNN2)
D Soler, A Kerstetter-Fogle, A Young, P Rayman, J Finke, S Debanne, K Cooper, J Barnholtz-Sloan, A Sloan, T McCormick |
Molecular Immunology | 2022 |
|
Low Levels of Granulocytic Myeloid-Derived Suppressor Cells May Be a Good Marker of Survival in the Follow-Up of Patients With Severe COVID-19
C Jiménez-Cortegana, F Sánchez-Jiménez, A Pérez-Pérez, N Álvarez, A Sousa, L Cantón-Bulnes, T Vilariño-García, S Fuentes, S Martín, M Jiménez, A León-Justel, L de la Cruz-Merino, J Garnacho-Montero, V Sánchez-Margalet |
Frontiers in immunology | 2022 |
|
An experimental in silico study on COVID‐19: Response of neutrophil‐related genes to antibiotics
S Mousavi, H Lotfi, S Salmanizadeh, S Feizbakhshan, F Khosravian, M Sajjadi, S Komachali, F Beni, B Torkan, M Kazemi, R Sami, M Salehi |
2022 | |
|
Erythrocytes Induce Vascular Dysfunction in COVID-19
A Mahdi, A Collado, J Tengbom, T Jiao, T Wodaje, N Johansson, F Farnebo, A Färnert, J Yang, J Lundberg, Z Zhou, J Pernow |
JACC: Basic to Translational Science | 2022 |
|
Targeting Arginine in COVID-19-Induced Immunopathology and Vasculopathy
W Durante |
Metabolites | 2022 |
|
Comparison of Lung-Homing Receptor Expression and Activation Profiles on NK Cell and T Cell Subsets in COVID-19 and Influenza
D Brownlie, I Rødahl, R Varnaite, H Asgeirsson, H Glans, S Falck-Jones, S Vangeti, M Buggert, H Ljunggren, J Michaëlsson, S Gredmark-Russ, A Smed-Sörensen, N Marquardt |
Frontiers in immunology | 2022 |
|
Role of T Regulatory Cells and Myeloid-Derived Suppressor Cells in COVID-19
A Alsalman, M Al-Mterin, E Elkord, M Dwivedi |
Journal of Immunology Research | 2022 |
|
Myeloid-Derived Suppressor Cells in COVID-19: The Paradox of Good
Grassi G, Notari S, Gili S, Bordoni V, Casetti R, Cimini E, Tartaglia E, Mariotti D, Agrati C, Sacchi A |
Frontiers in immunology | 2022 |
|
Myeloid-derived suppressor cells in COVID-19: A review
Perfilyeva YV, Ostapchuk YO, Tleulieva R, Kali A, Abdolla N, Krasnoshtanov VK, Perfilyeva AV, Belyaev NN |
Clinical Immunology | 2022 |
|
Considering innate immune responses in SARS-CoV-2 infection and COVID-19
Diamond MS, Lambris JD, Ting JP, Tsang JS |
Nature reviews. Immunology | 2022 |
|
Monocytic-Myeloid Derived Suppressor Cells Suppress T-Cell Responses in Recovered SARS CoV2-Infected Individuals
Beliakova-Bethell N, Maruthai K, Xu R, Salvador LC, Garg A |
Frontiers in immunology | 2022 |
|
COVID‐19 rapidly increases MDSCs and prolongs innate immune dysfunctions
Schrijver IT, Théroude C, Antonakos N, Regina J, Le Roy D, Bart P, Chiche J, Perreau M, Pantaleo G, Calandra T, Roger T |
European Journal of Immunology | 2022 |
|
Utility of Monocyte Expression of HLA-DR versus T Lymphocyte Frequency in the Assessment of COVID-19 Outcome
Hammad R, Kotb HG, Eldesoky GA, Mosaad AM, El-Nasser AM, Abd El Hakam FE, Eldesoky NA, Mashaal A, Farhoud H |
International journal of general medicine | 2022 |
|
Immunosuppressive Features of the Microenvironment in Lymph Nodes Granulomas from Tuberculosis and HIV–Co-Infected Patients
Ashenafi S, Muvva JR, Mily A, Snäll J, Zewdie M, Chanyalew M, Rehn A, Rahman S, Aseffa G, Bekele A, Aderaye G, Lema B, Svensson M, Brighenti S |
The American Journal of Pathology | 2022 |
|
Multi-omics personalized network analyses highlight progressive disruption of central metabolism associated with COVID-19 severity
Ambikan AT, Yang H, Krishnan S, Svensson Akusjärvi S, Gupta S, Lourda M, Sperk M, Arif M, Zhang C, Nordqvist H, Ponnan SM, Sönnerborg A, Treutiger CJ, O\u2019Mahony L, Mardinoglu A, Benfeitas R, Neogi U |
Cell Systems | 2022 |
|
Innate immunity to SARS-CoV-2 infection: a review
Silva MJ, Rodrigues YC, Lima KV, Lima LN |
Epidemiology and Infection | 2022 |
|
Serum-derived extracellular vesicles: Novel biomarkers reflecting the disease severity of COVID-19 patients.
Tertel T, Tomić S, Đokić J, Radojević D, Stevanović D, Ilić N, Giebel B, Kosanović M |
Journal of Extracellular Vesicles | 2022 |
|
The function of myeloid-derived suppressor cells in COVID-19 lymphopenia
Li T, Zheng F, Cheng F |
International Immunopharmacology | 2022 |
|
Difference in mortality rates in hospitalized COVID-19 patients identified by cytokine profile clustering using a machine learning approach: An outcome prediction alternative
Castro-Castro AC, Figueroa-Protti L, Molina-Mora JA, Rojas-Salas MP, Villafuerte-Mena D, Suarez-Sánchez MJ, Sanabría-Castro A, Boza-Calvo C, Calvo-Flores L, Solano-Vargas M, Madrigal-Sánchez JJ, Sibaja-Campos M, Silesky-Jiménez JI, Chaverri-Fernández JM, Soto-Rodríguez A, Echeverri-McCandless A, Rojas-Chaves S, Landaverde-Recinos D, Weigert A, Mora J |
Frontiers in Medicine | 2022 |
|
The immune response as a double‐edged sword: The lesson learnt during the COVID‐19 pandemic
Agrati C, Carsetti R, Bordoni V, Sacchi A, Quintarelli C, Locatelli F, Ippolito G, Capobianchi MR |
Immunology | 2022 |
|
Respiratory and systemic monocytes, dendritic cells, and myeloid‐derived suppressor cells in COVID‐19: Implications for disease severity
Falck\u2010Jones S, Österberg B, Smed\u2010Sörensen A |
Journal of Internal Medicine | 2022 |
|
Booster dose of mRNA vaccine augments waning T cell and antibody responses against SARS-CoV-2.
Özbay Kurt FG, Lepper A, Gerhards C, Roemer M, Lasser S, Arkhypov I, Bitsch R, Bugert P, Altevogt P, Gouttefangeas C, Neumaier M, Utikal J, Umansky V |
Frontiers in immunology | 2022 |
|
Cellular immune states in SARS-CoV-2-induced disease
Mortezaee K, Majidpoor J |
Frontiers in immunology | 2022 |
|
Immunophenotype and function of circulating myeloid derived suppressor cells in COVID-19 patients
Kiaee F, Jamaati H, Shahi H, Roofchayee ND, Varahram M, Folkerts G, Garssen J, Adcock IM, Mortaz E |
Scientific Reports | 2022 |
|
Adoptively Transferred in vitro-Generated Myeloid-Derived Suppressor Cells Improve T-Cell Function and Antigen-Specific Immunity after Traumatic Lung Injury
Kustermann M, Dasari P, Knape I, Keltsch E, Liu J, Pflüger S, Osen W, Holzmann K, Huber-Lang M, Debatin KM, Strauss G |
Journal of Innate Immunity | 2022 |
|
Stroke-induced changes to immune function and their relevance to increased risk of severe COVID-19 disease.
McCulloch L, Mouat IC, South K, McColl BW, Allan SM, Smith CJ |
2022 | |
|
Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination
Alberto Cagigi, Meng Yu, Björn Österberg, Julia Svensson, Sara Falck-Jones, Sindhu Vangeti, Eric Åhlberg, Lida Azizmohammadi, Anna Warnqvist, Ryan Falck-Jones, Pia Gubisch, Mert Ödemis, Farangies Ghafoor, Mona Eisele, Klara Lenart, Max Bell, Niclas Johansson, Jan Albert, Jörgen Sälde, Deleah D Pettie, Michael P. Murphy, Lauren Carter, Neil P King, Sebastian Ols, Johan Normark, Clas Ahlm, Mattias N Forsell, Anna Färnert, Karin Loré, Anna Smed-Sörensen |
JCI Insight | 2021 |
|
Role of myeloid-derived suppressor cells in viral respiratory infections; Hints for discovering therapeutic targets for COVID-19
K Koushki, M Salemi, SM Miri, Y Arjeini, M Keshavarz, A Ghaemi |
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie | 2021 |
|
Severe COVID-19 Is Characterized by an Impaired Type I Interferon Response and Elevated Levels of Arginase Producing Granulocytic Myeloid Derived Suppressor Cells
MJ Dean, JB Ochoa, MD Sanchez-Pino, J Zabaleta, J Garai, LD Valle, D Wyczechowska, LB Baiamonte, P Philbrook, R Majumder, RS Heide, L Dunkenberger, RP Thylur, B Nossaman, WM Roberts, AG Chapple, J Wu, C Hicks, J Collins, B Luke, R Johnson, HK Koul, CA Rees, CR Morris, J Garcia-Diaz, AC Ochoa |
Frontiers in immunology | 2021 |
|
The pathogenic role of epithelial and endothelial cells in early-phase COVID-19 pneumonia: victims and partners in crime
M Chilosi, V Poletti, C Ravaglia, G Rossi, A Dubini, S Piciucchi, F Pedica, V Bronte, G Pizzolo, G Martignoni, C Doglioni |
Modern Pathology | 2021 |
|
Myeloid cells in COVID-19 microenvironment
G Qin, S Liu, L Yang, W Yu, Y Zhang |
Signal Transduction and Targeted Therapy | 2021 |
|
Monocytes and Macrophages in COVID-19
R Knoll, JL Schultze, J Schulte-Schrepping |
Frontiers in immunology | 2021 |
|
Comorbidity-associated glutamine deficiency is a predisposition to severe COVID-19
T Matsuyama, SK Yoshinaga, K Shibue, TW Mak |
Cell Death and Differentiation | 2021 |
|
Neutrophils and lymphopenia, an unknown axis in severe COVID-19 disease
HF Peñaloza, JS Lee, P Ray, TE Morrison |
PLoS pathogens | 2021 |
|
A core-shell structured COVID-19 mRNA vaccine with favorable biodistribution pattern and promising immunity
R Yang, Y Deng, B Huang, L Huang, A Lin, Y Li, W Wang, J Liu, S Lu, Z Zhan, Y Wang, R A, W Wang, P Niu, L Zhao, S Li, X Ma, L Zhang, Y Zhang, W Yao, X Liang, J Zhao, Z Liu, X Peng, H Li, W Tan |
Signal Transduction and Targeted Therapy | 2021 |
|
Hallmarks of immune response in COVID-19: Exploring dysregulation and exhaustion
A Mazzoni, L Salvati, L Maggi, F Annunziato, L Cosmi |
Seminars in Immunology | 2021 |
|
Immune profiling of COVID-19: preliminary findings and implications for the pandemic
HT Maecker |
Journal for ImmunoTherapy of Cancer | 2021 |
|
Mild and Asymptomatic COVID-19 Convalescents Present Long-Term Endotype of Immunosuppression Associated With Neutrophil Subsets Possessing Regulatory Functions
I Siemińska, K Węglarczyk, M Surmiak, D Kurowska-Baran, M Sanak, M Siedlar, J Baran |
Frontiers in immunology | 2021 |
|
COVID-19, what could sepsis, severe acute pancreatitis, gender differences, and aging teach us?
CG Gallo, S Fiorino, G Posabella, D Antonacci, A Tropeano, E Pausini, C Pausini, T Guarniero, W Hong, E Giampieri, I Corazza, L Federico, D de Biase, M Zippi, M Zancanaro |
Cytokine | 2021 |
|
Alterations in Circulating Monocytes Predict COVID-19 Severity and Include Chromatin Modifications Still Detectable Six Months after Recovery
A Utrero-Rico, C González-Cuadrado, M Chivite-Lacaba, O Cabrera-Marante, R Laguna-Goya, P Almendro-Vazquez, C Díaz-Pedroche, M Ruiz-Ruigómez, A Lalueza, MD Folgueira, E Vázquez, A Quintas, MJ Berges-Buxeda, M Martín-Rodriguez, A Dopazo, A Serrano-Hernández, JM Aguado, E Paz-Artal |
Biomedicines | 2021 |
|
Myeloid-Derived Suppressor Cells as a Potential Biomarker and Therapeutic Target in COVID-19
M Rowlands, F Segal, D Hartl |
Frontiers in immunology | 2021 |
|
Immunity to SARS‐CoV‐2 induced by infection or vaccination
XC Dopico, S Ols, K Loré, GB Hedestam |
Journal of Internal Medicine | 2021 |
|
Correlation of myeloid‐derived suppressor cells with C‐reactive protein, ferritin and lactate dehydrogenase levels in patients with severe COVID‐19
A Emsen, S Sumer, B Tulek, H Cizmecioglu, H Vatansev, MH Goktepe, F Kanat, Y Koksal, U Arslan, H Artac |
Scandinavian Journal of Immunology | 2021 |
|
l-Arginine and COVID-19: An Update
A Adebayo, F Varzideh, S Wilson, J Gambardella, M Eacobacci, SS Jankauskas, K Donkor, U Kansakar, V Trimarco, P Mone, A Lombardi, G Santulli |
Nutrients | 2021 |
|
Expansion of Myeloid Derived Suppressor Cells Contributes to Platelet Activation by L-Arginine Deprivation during SARS-CoV-2 Infection
A Sacchi, G Grassi, S Notari, S Gili, V Bordoni, E Tartaglia, R Casetti, E Cimini, D Mariotti, G Garotto, A Beccacece, L Marchioni, M Bibas, E Nicastri, G Ippolito, C Agrati |
Cells | 2021 |
|
White button mushroom interrupts tissue AR-mediated TMPRSS2 expression and attenuates pro-inflammatory cytokines in C57BL/6 mice
X Wang, D Ha, R Yoshitake, S Chen |
npj Science of Food | 2021 |
|
White Button Mushroom (Agaricus bisporus) Interrupts Tissue AR-TMPRSS2 Expression and Attenuates Pro-inflammatory Cytokines in C57BL/6 Mice: Implication for COVID-19 Dietary Intervention
Shiuan Chen, Xiaoqiang Wang, Desiree Ha, Ryohei Yoshitake |
Research square | 2021 |
|
Metformin to decrease COVID-19 severity and mortality: Molecular mechanisms and therapeutic potential
Kamyshnyi O, Matskevych V, Lenchuk T, Strilbytska O, Storey K, Lushchak O |
Biomedicine & Pharmacotherapy | 2021 |
Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)